cdmo.directory
← Compare landing

Bramble Bio vs Cell-Easy

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/bramble-bio/cell-easy

CategoryBramble BioCell-Easy
Listed sitecdmocdmo
SummaryBramble Bio specializes in cGMP manufacturing and process development for cell therapy ATIMPs, including autologous and allogeneic therapies, with 20+ years of expertise, 16 Grade B cleanrooms, and support for over 8,000 dosed patients across 46 countries.Cell-Easy is a CDMO specializing in development and GMP manufacturing of cell therapies, with expertise across T cells, NK cells, MSCs, and iPSCs. The company has manufactured over 1,000 clinical doses and supports 50+ development programs from process optimization through regulatory compliance.
Services
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • Cold-Chain Storage & Logistics
  • Cell Therapy Manufacturing
  • Process Development
  • CMC Analytical Development
  • Cell-Line Development
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
Modalities
  • Cell Therapy
  • Cell Therapy
IndicationsData not yet provided.
  • Oncology
  • Immunology
Locations
  • Headquarters, Europe
  • Cryopreservation & Distribution Network, Europe, Middle East, Asia (15 facilities)
  • Headquarters, Toulouse, Occitanie, France
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.